Circulating megakaryocyte and platelet microvesicles correlate with response to ruxolitinib and distinct disease severity in patients with myelofibrosis

Martina Barone; Francesca Ricci; Daria Sollazzo; Emanuela Ottaviani; Marco Romano; Giuseppe Auteri; Daniela Bartoletti; Maria L.B. Reggiani; Nicola Vianelli; Pier L. Tazzari; Michele Cavo; Dorian Forte; Francesca Palandri; Lucia Catani

doi:10.1111/bjh.15682

Circulating megakaryocyte and platelet microvesicles correlate with response to ruxolitinib and distinct disease severity in patients with myelofibrosis

Martina Barone, Francesca Ricci, Daria Sollazzo, Emanuela Ottaviani, Marco Romano, Giuseppe Auteri, Daniela Bartoletti, Maria L.B. Reggiani, Nicola Vianelli, Pier L. Tazzari, Michele Cavo, Dorian Forte, Francesca Palandri, Lucia Catani^*

^*Corresponding author for this work

Peter Gorer Department of Immunobiology

Research output: Contribution to journal › Letter › peer-review

17 Citations (Scopus)

Original language	English
Pages (from-to)	987-991
Number of pages	5
Journal	British Journal of Haematology
Volume	185
Issue number	5
Early online date	22 Nov 2018
DOIs	https://doi.org/10.1111/bjh.15682
Publication status	Published - 1 Jun 2019

Keywords

essential thrombocythaemia
megakaryocytopoiesis
microvesicles
myelofibrosis
platelet activation
ruxolitinib

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/bjh.15682

Cite this

Barone, M., Ricci, F., Sollazzo, D., Ottaviani, E., Romano, M., Auteri, G., Bartoletti, D., Reggiani, M. L. B., Vianelli, N., Tazzari, P. L., Cavo, M., Forte, D., Palandri, F., & Catani, L. (2019). Circulating megakaryocyte and platelet microvesicles correlate with response to ruxolitinib and distinct disease severity in patients with myelofibrosis. British Journal of Haematology, 185(5), 987-991. https://doi.org/10.1111/bjh.15682

@article{0f1dbc0ed8ea41a49480ccb5a770832f,

title = "Circulating megakaryocyte and platelet microvesicles correlate with response to ruxolitinib and distinct disease severity in patients with myelofibrosis",

keywords = "essential thrombocythaemia, megakaryocytopoiesis, microvesicles, myelofibrosis, platelet activation, ruxolitinib",

author = "Martina Barone and Francesca Ricci and Daria Sollazzo and Emanuela Ottaviani and Marco Romano and Giuseppe Auteri and Daniela Bartoletti and Reggiani, {Maria L.B.} and Nicola Vianelli and Tazzari, {Pier L.} and Michele Cavo and Dorian Forte and Francesca Palandri and Lucia Catani",

year = "2019",

month = jun,

day = "1",

doi = "10.1111/bjh.15682",

language = "English",

volume = "185",

pages = "987--991",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "5",

}

Barone, M, Ricci, F, Sollazzo, D, Ottaviani, E, Romano, M, Auteri, G, Bartoletti, D, Reggiani, MLB, Vianelli, N, Tazzari, PL, Cavo, M, Forte, D, Palandri, F & Catani, L 2019, 'Circulating megakaryocyte and platelet microvesicles correlate with response to ruxolitinib and distinct disease severity in patients with myelofibrosis', British Journal of Haematology, vol. 185, no. 5, pp. 987-991. https://doi.org/10.1111/bjh.15682

TY - JOUR

T1 - Circulating megakaryocyte and platelet microvesicles correlate with response to ruxolitinib and distinct disease severity in patients with myelofibrosis

AU - Barone, Martina

AU - Ricci, Francesca

AU - Sollazzo, Daria

AU - Ottaviani, Emanuela

AU - Romano, Marco

AU - Auteri, Giuseppe

AU - Bartoletti, Daniela

AU - Reggiani, Maria L.B.

AU - Vianelli, Nicola

AU - Tazzari, Pier L.

AU - Cavo, Michele

AU - Forte, Dorian

AU - Palandri, Francesca

AU - Catani, Lucia

PY - 2019/6/1

Y1 - 2019/6/1

KW - essential thrombocythaemia

KW - megakaryocytopoiesis

KW - microvesicles

KW - myelofibrosis

KW - platelet activation

KW - ruxolitinib

U2 - 10.1111/bjh.15682

DO - 10.1111/bjh.15682

M3 - Letter

C2 - 30450539

AN - SCOPUS:85056713833

SN - 0007-1048

VL - 185

SP - 987

EP - 991

JO - British Journal of Haematology

JF - British Journal of Haematology

IS - 5

ER -